Inhaled insulin: weighing up the benefits and practical concerns

Inhaled insulin: promises and concerns.

Since the introduction of Pfizer Exubera in the early 1990s, a number of other inhaled insulin solutions have been developed. This article provides an overview of inhaled insulin systems developed by Pfizer, Novo Nordisk, MannKind, and Lilly, three of which are currently in phase 3 trials. The strengths and weaknesses of each product, as well as the general technologies (liquid vs dry powder), ...

Brazilian daycares: weighing the risks and benefits.

The number of day care centers in Brazil has doubled over the last few years; with this increase has come a rise in the numbers of cases of communicable disease, particularly pneumonia (the main cause of child mortality in Brazil). A study by Dr. Walter V.C. da Fonseca states that a day care child is 5 times more likely to contact pneumonia. However, since the income earned by women in Brazil...

Weighing the risks and benefits of tamoxifen.

Nanosilver: Weighing the Risks and Benefits

Silver nanoparticles are added to a variety of textiles and home goods as an antimicrobial. Although silver has been used safely for centuries, some question whether the rapid expansion of new exposure sources to nanosilver could have adverse consequences.

Alcohol consumption in the new millennium – weighing up the risks and benefits for our health